Stress Response in Neurodegeneration explores the critical role that chronic stress and dysregulated stress response pathways play in the pathogenesis of neurodegenerative diseases. This page covers the HPA axis, cellular stress responses, and their implications for Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease.
The stress response system is a crucial mechanism for maintaining cellular homeostasis in the face of environmental and physiological challenges. However, chronic dysregulation of these pathways can contribute to neurodegeneration. Understanding the interplay between stress hormones, cellular stress responses, and neuronal vulnerability is essential for developing therapeutic interventions.
Chronic stress and dysregulated stress response pathways play significant roles in neurodegenerative disease pathogenesis. The hypothalamic-pituitary-adrenal (HPA) axis and cellular stress responses contribute to neuronal vulnerability.
- Corticotropin-releasing hormone (CRH): Primary regulator
- Adrenocorticotropic hormone (ACTH): Pituitary output
- Cortisol: Glucocorticoid output
- Feedback inhibition: Negative feedback loops
- Heat shock proteins: Protein quality control
- Unfolded protein response (UPR): ER stress
- Oxidative stress response: ROS detoxification
- DNA damage response: Genomic integrity
- Cortisol elevation: Memory impairment
- HPA axis dysregulation: Early feature
- Glucocorticoid toxicity: Neuronal vulnerability
- CRH deficits: Synaptic plasticity
- Stress vulnerability: Dopaminergic neurons
- Cortisol alterations: Disease progression
- α-Synuclein interaction: Stress enhances aggregation
- ER stress: Motor neuron vulnerability
- Protein aggregation: Cellular stress
- Oxidative damage: Common pathway
- Stress pathway dysregulation: Early event
- Transcription effects: Gene expression changes
- Aggregation: Stress enhances formation
- Neuronal excitability: Altered calcium handling
- Synaptic plasticity: Impaired LTP/LTD
- Energy metabolism: Mitochondrial effects
- Neuroinflammation: Microglial activation
- PERK pathway: Translation attenuation
- IRE1 pathway: XBP1 splicing
- ATF6 pathway: CHOP expression
- Apoptosis: Prolonged activation
- ROS production: Mitochondrial dysfunction
- Antioxidant depletion: GSH, SOD
- DNA damage: Accumulation
- Protein oxidation: Aggregation
- GR antagonists: Block glucocorticoid effects
- CRH modulators: Normalize HPA axis
- Antioxidants: Reduce oxidative stress
- UPR modulators: Enhance protein clearance
- Stress resilience: Lifestyle interventions
The study of Stress Response In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Sapolsky RM. (2000). Stress hormones: good and bad. Neurobiol Aging. PMID:10858598.
- McEwen BS. (2008). Central effects of stress hormones in health and disease. Nat Rev Neurosci. PMID:18445490.
- Lupien SJ, et al. (2009). Effects of stress throughout the lifespan on the brain. Nat Rev Neurosci. PMID:19588316.
- de Kloet ER, et al. (2005). Stress and the brain: from adaptation to disease. Nat Rev Neurosci. PMID:16238581.
- Green KN, et al. (2006). Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci. PMID:17082461.
- Peeters GG, et al. (2021). Stress and neurodegeneration. Nat Rev Neurosci. PMID:34511653.
- Mravec B. (2011). The role of the hypothalamic-pituitary-adrenal axis in neurodegeneration. Neuro Endocrinol Lett. PMID:21876469.
- Herman JP, et al. (2016). Neural regulation of stress response. Adv Psychosom Med. PMID:27215781.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
8 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
33% |
| Mechanistic Completeness |
50% |
Overall Confidence: 34%